Catheter ablation of atrial fibrillation results in significant QTc prolongation in the postoperative period
Autor: | Deanna Tregoning, Jonathan Hourmozdi, Basil Saour, Arun Sridhar, Neal A. Chatterjee, Jordan M. Prutkin, Dan D. Nguyen, Nazem Akoum, Melissa R. Robinson |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
QTC PROLONGATION
congenital hereditary and neonatal diseases and abnormalities medicine.medical_specialty medicine.medical_treatment Catheter ablation Ablation QT interval Pulmonary vein isolation Pulmonary vein Clinical Prolonged QT QTc Internal medicine medicine cardiovascular diseases business.industry Incidence (epidemiology) Retrospective cohort study Atrial fibrillation medicine.disease Cohort Cardiology cardiovascular system business circulatory and respiratory physiology |
Zdroj: | Heart Rhythm O2 |
ISSN: | 2666-5018 |
Popis: | Background The corrected QT interval (QTc) is a measure of ventricular repolarization time, and a prolonged QTc increases risk for malignant ventricular arrhythmias. Pulmonary vein isolation (PVI) may increase QTc but its effects have not been well studied. Objective Determine the incidence, risk factors, and outcomes of patients presenting for PVI in sinus and atrial fibrillation with postoperative QTc prolongation in a large cohort. Methods We performed a single-center retrospective study of consecutive atrial fibrillation ablations. QTc durations using Bazett correction were obtained from electrocardiograms at different postoperative intervals and compared to preoperative QTc. We studied clinical outcomes including clinically significant ventricular arrhythmia and death. A multivariable model was used to identify factors associated with clinically significant QTc prolongation, defined as ΔQTc ≥60 ms or new QTc duration ≥500 ms. Results A total of 352 PVIs were included in this study. We observed a statistically significant increase in mean QTc compared to baseline (446.3 ± 37.8 ms) on postoperative day (POD)0 (471.7 ± 38.2 ms, P < .001) and at POD1 (456.5 ± 35.0 ms, P < .001). There was no significant difference at 1 month (452.4 ± 33.5 ms, P = .39) and 3 months (447.3 ± 40.0 ms, P = .78). Sixty-six patients (19.2%) developed ΔQTc ≥60 ms or QTc ≥500 ms on POD0, with 4.1% persisting past 90 days. Female sex (odds ratio [OR] = 1.82, 95% confidence interval [CI] =1.01–3.29, P = .047) and history of coronary artery disease (OR = 2.16, 95% CI = 1.03–4.55, P = .042) were independently predictive of QTc prolongation ≥500 ms or ΔQTc ≥60 ms. There were no episodes of clinically significant ventricular arrhythmia or death attributable to arrhythmia. Conclusion QTc duration increased significantly immediately post-PVI and returned to baseline by 1 month. PVI did not provoke significant ventricular arrhythmias in our cohort. Graphical abstract |
Databáze: | OpenAIRE |
Externí odkaz: |